<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02634957</url>
  </required_header>
  <id_info>
    <org_study_id>PRO15120009</org_study_id>
    <nct_id>NCT02634957</nct_id>
  </id_info>
  <brief_title>Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery</brief_title>
  <official_title>Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Absolute voice rest is commonly prescribed after vocal fold surgery, also known as
      phonomicrosurgery, for benign vocal fold lesions. This is thought to decrease scarring of
      vocal folds, which could result in increasing tissue stiffness and limitations in optimal
      vocal outcome. Unfortunately there is no standardized protocol as to how long patients should
      rest their voice after phonomicrosurgery. To date, there are no studies in the literature
      directly comparing the impact of short-term and long-term voice rest on vocal fold healing
      and voice outcome after phonomicrosurgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine whether 3 days versus 7 days of absolute voice rest
      will result in different voice outcomes in patients who have undergone phonomicrosurgery for
      benign vocal fold lesions.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to change in available resources
  </why_stopped>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Voice Handicap Index - 10</measure>
    <time_frame>3 months post op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Voice Handicap Index - 10</measure>
    <time_frame>1 month post op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cepstral Peak Prominence (CPP)</measure>
    <time_frame>1 month and 3 months post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average phonatory airflow in all voiced sentence</measure>
    <time_frame>1 month and 3 months post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>video stroboscopy findings</measure>
    <time_frame>1 month and 3 months post op</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Benign Neoplasm of True Vocal Cords</condition>
  <arm_group>
    <arm_group_label>3 day absolute voice rest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants would begin initiation of voice/speaking 3 days post phonomicrosurgery for benign vocal fold lesions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7 day absolute voice rest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants would begin initiation of voice/speaking 7 days post phonomicrosurgery for benign vocal fold lesions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>absolute voice rest</intervention_name>
    <description>absolute voice rest is the complete elimination of any vocalization (no sounds, speaking or whispering)</description>
    <arm_group_label>3 day absolute voice rest</arm_group_label>
    <arm_group_label>7 day absolute voice rest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with benign mid membranous vocal fold lesions such as the following:

               1. Polyps

               2. Cysts

               3. Sub-epithelial fibrous mass

          2. Undergoing elective phonomicrosurgery for vocal fold lesions, which involves microflap
             excision +/- truncation +/- steroid injection into the vocal folds.

          3. Age 18 and older

        Exclusion Criteria:

        Patients with any of the following will be excluded from the study:

          1. Reinke's edema

          2. Active smokers

          3. Ligamentous mid membranous vocal fold lesions

          4. RRP (Recurrent Respiratory Papillomatosis)

          5. Dysplasia

          6. CIS (Carcinoma-in-situ)

          7. SCC (squamous cell carcinoma)

          8. Extent of surgery exceeds what is mentioned in the inclusion criteria (e.g., CO2
             laser, balloon dilatation, vocal fold augmentation in addition to phonomicrosurgery)

          9. Previous vocal fold surgery

         10. Systemic steroids

         11. History of systemic illness that could affect wound healing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Libby Smith, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 11, 2015</study_first_submitted>
  <study_first_submitted_qc>December 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2015</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Libby Smith DO</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>phonomicrosurgery</keyword>
  <keyword>benign vocal fold lesions</keyword>
  <keyword>voice rest</keyword>
  <keyword>vhi-10</keyword>
  <keyword>CPP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>de-identified information with outside collaborators</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>information may be shared during and after collection for the purpose of analysis</ipd_time_frame>
    <ipd_access_criteria>if not part of original IRB, sharing will only occur if there is a data use agreement executed.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

